225 / 864
224
Bibliografía
1. Gross P. Clinical management of SIADH. Ther Adv Endocrinol Metab 2012;3(2):61-73.
2. Torres A, Wickham E, Biscobing D. Tolvaptan for the management of SIADH. Endocr Pract 2011;17(4):
97-100.
3. Fenske W, Sandner B, Christ-Crain M. A copeptin-based classification of the osmoregulatory defects in
the syndrome of inappropiate antidiuresis. Best Practice & Research Clinical Endocrinology & Metabolism.
2016;30:219-33.
4. Álvarez E, González E. Bases fisiopatológicas de los trastornos del sodio en pediatría. Rev Chil Pediatr.
2014;85(3):269-280.
5. Cuesta M, Thompson CJ. The syndrome of inappropiate antidiuresis. Best Pract Res Clin Endocrinol
Metab. 2016;30(2):175-87.
6. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hipo-
natremia. Nephrol Dial Transplant. 2014;29(2):1-39.
7. Ellison DH, Berl T. Clinical Practice. The syndrome of inappropiate antidiuresis. N Engl J Med. 2007;256:
2064-72.
8. Young Lee J, Kilonzo K, Nistico A, et al. Management of hiponatremia. CMAJ. 2014;186(8):281-6.
9. Runkle I, Villabona C, Navarro A, et al. Tratamiento de la hiponatremia secundaria al síndrome de secre-
ción inadecuada de la hormona antidiurética: algoritmo multidisciplinar. Nefrologia (Madr.) 2014;34:439-
50.